149 related articles for article (PubMed ID: 21453237)
1. Treatment of chronic ascites due to right-sided heart failure by transjugular intrahepatic portosystemic shunt stent-implantation after orthotopic heart transplant.
Dakkak AR; Welp H; Schmidt H; Koehler M; Scheld HH; Sindermann JR
Exp Clin Transplant; 2011 Apr; 9(2):156-8. PubMed ID: 21453237
[TBL] [Abstract][Full Text] [Related]
2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
3. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt for intractable posthepatectomy ascites.
Hwang S; Park KM; Lee SG; Sung KB; Lee YJ; Choi DN; Ahn CS; Min PC
Hepatogastroenterology; 2002; 49(48):1669-72. PubMed ID: 12397761
[TBL] [Abstract][Full Text] [Related]
5. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for a wait list patient is not a contraindication for orthotopic liver transplant outcomes.
Levi Sandri GB; Lai Q; Lucatelli P; Melandro F; Guglielmo N; Mennini G; Berloco PB; Fanelli F; Salvatori FM; Rossi M
Exp Clin Transplant; 2013 Oct; 11(5):426-8. PubMed ID: 23745783
[TBL] [Abstract][Full Text] [Related]
7. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
[TBL] [Abstract][Full Text] [Related]
8. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt for liver transplantation.
Zhou GW; Cai WY; Li HW; Zhu Y; Dodson F; Fung JJ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):179-82. PubMed ID: 14607734
[TBL] [Abstract][Full Text] [Related]
11. Torulopsis glabrata fungemia from infected transjugular intrahepatic portosystemic shunt stent.
Brickey TW; Trotter JF; Johnson SP
J Vasc Interv Radiol; 2005 May; 16(5):751-2. PubMed ID: 15872333
[TBL] [Abstract][Full Text] [Related]
12. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
[TBL] [Abstract][Full Text] [Related]
13. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
[TBL] [Abstract][Full Text] [Related]
14. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
15. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
17. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
18. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
Therapondos G; Wong F
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
[TBL] [Abstract][Full Text] [Related]
19. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial.
Sauer P; Theilmann L; Herrmann S; Bruckner T; Roeren T; Richter G; Stremmel W; Stiehl A
Hepatology; 1996 Dec; 24(6):1433-6. PubMed ID: 8938176
[TBL] [Abstract][Full Text] [Related]
20. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
Nair S; Singh R; Yoselewitz M
J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
